Statement on Final House Passage of Food and Drug Adminstration Safety and Innovation Act

We applaud final House passage of the reauthorization of the Food and Drug Administration Safety and Innovation Act.

Key Resources

Related Resources

Advisory
AHA and Health-ISAC Joint Threat Bulletin: Actionable Indicators of Compromise Related to Recent Health Care Ransomware Attacks
Member
Letter/Comment
AHA Comments on FTC Anticompetitive Deregulations RFI
Public
Letter/Comment
AHA Comments on DOJ Anticompetitive Deregulations RFI
Public
Advisory
AHA Summary of One Big Beautiful Bill Act’s Provisions Impacting Hospitals and Health Systems
Member Non-Fed
Special Bulletin
House Passes Reconciliation Bill with Significant Policy Changes and Reductions to Medicaid, Other Health Care Programs
Member Non-Fed
Letter/Comment
AHA Senate Letter Supporting Improving Seniors’ Timely Access to Care Act
Public